Pfizer’s blood clot drug Fragmin gets FDA approval for pediatric patients

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 17, 2019 at 10:02 AM.

  1. #1 cafead, May 17, 2019 at 10:02 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Pfizer has secured approval from the US Food and Drug Administration (FDA) for the subcutaneous use of Fragmin (dalteparin sodium) injection for the treatment of potentially life-threatening blood clots in pediatric patients.

    article source
     
    Quote

Reply to Thread